Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 236

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Comparison of FIB‐4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non‐alcoholic fatty liver disease: A meta‐analysis study

Sun, Wenjing, Cui, Hongli, Li, Ning, Wei, Yanling, Lai, Shujie, Yang, Yang, Yin, Xinru, Chen, Dong‐Feng · 2016 · Hepatology Research

Abstract

Aim: Non‐alcoholic fatty liver disease (NAFLD)‐related advanced hepatic fibrosis is associated with liver and cardiovascular morbidity and mortality. This study aims to compare the FIB‐4 index, NAFLD fibrosis score (NFS) and BARD score for prediction of advanced liver fibrosis. Methods: Pooled sensitivity, specificity, diagnostic odds ratio (DOR), summary receiver–operator curves (SROC) and Spearman's rank correlation coefficient were used to examine the accuracy of each non‐invasive scoring system for predicting NAFLD‐related advanced fibrosis. Results: Four studies with 1038 adult patients were included in this meta‐analysis. A total of 135 patients (13.0%) had advanced fibrosis. In the FIB‐4 index group, pooled sensitivity and specificity with 95% confidence interval (CI), and the area under the ROC (AUROC) were 0.844 (0.772–0.901), 0.685 (0.654–0.716) and 0.8496 ± 0.0680, respectively, at a cut‐off of 1.30. At a threshold of 3.25, the same parameters were 0.38 (0.30–0.47), 0.96 (0.95–0.98) and 0.8445 ± 0.0981. At a cut‐off of −1.455, values were 0.77 (0.69–0.84), 0.70 (0.67–0.73) and 0.8355 ± 0.0667, respectively. At a 0.676 cut‐off, pooled sensitivity and specificity with 95% CI were 0.27 (0.19–0.35) and 0.98 (0.96–0.98), respectively; and the AUROC was 0.647 ± 0.2208. In the BARD score group, pooled sensitivity and specificity with 95% CI were 0.74 (0.66–0.81) and 0.66 (0.63–0.69), respectively; and the AUROC was 0.7625 ± 0.0285. Conclusion: FIB‐4 index with a 1.30 cut‐off has better diagnostic accuracy than the FIB‐4 index with a 3.25 cut‐off, NFS and BARD score, despite showing its limited value for predicting NAFLD‐related advanced fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/hepr.12647

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 236

Metadata

Authors
Sun, W., Cui, H., Li, N., Wei, Y., Lai, S., Yang, Y., Yin, X., & Chen, D.
Venue
Hepatology Research
Publisher
Wiley
Published
2016-02-16
Volume
46
Issue
9
Pages
862-870
ISSN
  • 1386-6346 (ISSN-L)
  • 1872-034X
OpenAlex
W2421099511
Cited by
236
References
5
FWCI
8.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of FIB‐4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non‐alcoholic fatty liver disease: A meta‐analysis study. https://app.cochat.ai/papers/10.1111/hepr.12647
The paper
Sun, W., Cui, H., Li, N., Wei, Y., Lai, S., Yang, Y., Yin, X., & Chen, D. (2016). Comparison of FIB‐4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non‐alcoholic fatty liver disease: A meta‐analysis study. Hepatology Research. https://doi.org/10.1111/hepr.12647

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.